Find the investors funding Health IPO rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
ADARx bags $446.3M IPO as another siRNA startup readies for its debut - firstwordpharma.com
ADARx is a startup focused on siRNA technology. The company has successfully raised $446.3 million through an IPO, indicating significant investor confidence in its potential within the biotechnology sector.
ADARx bags $446.3M IPO as another siRNA startup readies for its debut firstwordpharma.com
| Oct 22, 2026 | CureBay | $12.0M | Pre-Series C | India |
| Oct 22, 2026 | Vitalls | $1.5M | Seed | United Arab Emirates |
| Oct 21, 2026 | Genie Health | $3.0M | Seed | Singapore |
| Oct 20, 2026 | Cellbox | $5.3M | Series A | — |
You just read who funded ADARx. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.